Suchergebnisse - "Zhu, Yu-Yan"

PubPharm (13)

1

Comparison of the Profile and Management of Chronic Pancreatitis between China and Western Countries : A Single-Center Experience and Literature Review

enthalten in: Annali italiani di chirurgia | 2024

von Zhu, Y. | Li, H. | Fan, J. | +7

2

Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways

enthalten in: Journal of food biochemistry | 2022

von Zhu, Y. | Meng, X. | Zhou, Y. | +2

3

Major royal jelly proteins alleviate non‐alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways

enthalten in: Journal of food biochemistry | 2022

von Zhu, Y. | Meng, X. | Zhou, Y. | +2

4

Chrysin Improves Glucose and Lipid Metabolism Disorders by Regulating the AMPK/PI3K/AKT Signaling Pathway in Insulin-Resistant HepG2 Cells and HFD/STZ-Induced C57BL/6J Mice

enthalten in: Journal of agricultural and food chemistry | 2021

von Zhou, Y. | Xu, N. | Zhang, X. | +3

5

miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axis

enthalten in: OncoTargets and therapy | 2019

von Jing, Z. | Bi, J. | Li, Z. | +7

6

PKC α regulates netrin-1/UNC5B-mediated survival pathway in bladder cancer

enthalten in: BMC cancer | 2014

von Liu, J. | Kong, C. | Gong, D. | +2

7

PKC α regulates netrin-1/UNC5B-mediated survival pathway in bladder cancer

enthalten in: BMC cancer | 2014

von Liu, J. | Kong, C. | Gong, D. | +2

8

PKC α regulates netrin-1/UNC5B-mediated survival pathway in bladder cancer

enthalten in: BMC cancer | 2014

von Liu, J. | Kong, C. | Gong, D. | +2

9

The role of protein kinase C alpha in recurrence of superficial bladder carcinoma

enthalten in: Zhonghua wai ke za zhi [Chinese journal of surgery | 2005

von Zhu, Y. | Wang, H. | Kong, C. | +4

10

Expression of lung resistance-related protein gene in transitional cell carcinoma of the bladder

enthalten in: Zhonghua wai ke za zhi [Chinese journal of surgery | 2005

von Kong, C. | Zhu, Y. | Ma, Z. | +3